Carissa Chu

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

1.8Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Papers

Driven by 21 papers — median percentile 88. Top paper: “TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells”.

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005

N/A

3.3DataRank · unranked

88 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1283

Top 12%

1.8DataRank

Top 12%68 citations

Michal Sarfaty, Min Yuen Teo, Neha Ratna, Cihan Düzgöl, Samuel A. Funt +18 more

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175

N/A

0.758DataRank · unranked

156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

Scientific Reports(2021)10.1038/s41598-021-84507-z

N/A

0.657DataRank · unranked

79 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0.648DataRank · unranked

74 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0.489DataRank · unranked

25 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0.449DataRank · unranked

19 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

European Urology(2024)10.1016/j.eururo.2024.10.024

N/A

0.385DataRank · unranked

12 citations

Syed M. Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew Katims +34 more

Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non–muscle invasive bladder cancer

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.05.013

N/A

0.385DataRank · unranked

12 citations

Eugene J. Pietzak, Carissa Chu

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Nature Communications(2025)10.1038/s41467-025-62710-0

N/A

0.330DataRank · unranked

8 citations

Henry M. Delavan, Elizabeth Yip, Corynn Kasap, Jun Zhu, Roshan Lodha +21 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0.292DataRank · unranked

6 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0.269DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.567

N/A

0.241DataRank · unranked

4 citations

Manuel De Jesus Escano, Wesley Yip, Song Jiang, Gopa Iyer, Hikmat Al‐Ahmadie +6 more

Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.564

N/A

0.165DataRank · unranked

2 citations

Kwanghee Kim, Fengshen Kuo, Andrew T. Lenis, Jie‐Fu Chen, Wenhuo Hu +15 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730.v1

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Diagnostic Accuracy and Prognostic Value of Serial Prostate Multiparametric Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer

European Urology Oncology(2021)10.1016/j.euo.2020.11.007

N/A

0DataRank · unranked

28 citations

Janet E. Cowan, Peter E. Lonergan, Samuel L. Washington, Vittorio Fasulo, Claire M. de la Calle +4 more

Liposomal Bupivacaine Decreases Postoperative Length of Stay and Opioid Use in Patients Undergoing Radical Cystectomy

Urology(2020)10.1016/j.urology.2020.11.036

N/A

0DataRank · unranked

11 citations

Lauren Law, Kyle B. Zuniga, Tracy Kuo Lin, Candy Tsourounis, Rosa Rodríguez-Monguió +10 more

Cell-free DNA as a biomarker for prostate cancer: elevated concentration and decreased fragment size

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.26.215020

N/A

0DataRank · unranked

0 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3882

N/A

0DataRank · unranked

23 citations

Carissa Chu, Jonathan E. Rosenberg, David H. Aggen

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Carissa Chu

Indexed papers

Top data-sharing exemplar

Papers